Further investigations of the epitopes and immunogenicity of novel L-asparaginases are needed to assume their therapeutic applications or create the mutated proteins with minimized immunogenicity in order to increase the efficacy of leukemia treatment. This evidence concerns the gene ASPG and leukemia.